|
EP3087991A1
(en)
|
2003-11-08 |
2016-11-02 |
Prothera Biologics |
Composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
|
|
AU2006207954A1
(en)
*
|
2005-01-28 |
2006-08-03 |
Childrens Medical Center Corporation |
Methods for diagnosis and prognosis of epithelial cancers
|
|
US7851189B2
(en)
*
|
2005-03-07 |
2010-12-14 |
Boston Scientific Scimed, Inc. |
Microencapsulated compositions for endoluminal tissue engineering
|
|
WO2006133349A2
(en)
*
|
2005-06-08 |
2006-12-14 |
Alpharma, Inc. |
Orally disintegrable sleep aid formulations
|
|
US20080279921A1
(en)
*
|
2007-05-07 |
2008-11-13 |
Ceramoptec Industries, Inc. |
Gel-formulations of hydrophobic photosensitizers for mucosal applications
|
|
ES2926857T3
(es)
*
|
2006-05-18 |
2022-10-31 |
Biolitec Unternehmensbeteiligungs Ii Ag |
Formulaciones en gel de fotosensibilizantes hidrófobos para aplicaciones en mucosas
|
|
WO2009073457A1
(en)
*
|
2007-11-30 |
2009-06-11 |
Bausch & Lomb Incorporated |
Methods and compositions for the rescue of a filtering bleb
|
|
TR201808152T4
(tr)
|
2008-05-28 |
2018-07-23 |
Prothera Biologics Inc |
Kandan inter-alfa inhibitör proteinlerinin hazırlanması ve bunların bileşimi.
|
|
KR100935711B1
(ko)
|
2008-09-12 |
2010-01-07 |
김희구 |
생약 패드
|
|
GB0823472D0
(en)
*
|
2008-12-23 |
2009-01-28 |
Photocure Asa |
Product
|
|
US20100256125A1
(en)
*
|
2009-04-06 |
2010-10-07 |
Zila Pharmaceuticals, Inc. |
Use of improved toluidine blue in photodynamic therapy
|
|
KR101797780B1
(ko)
*
|
2009-06-11 |
2017-11-14 |
포토큐어 에이에스에이 |
반고체 조성물 및 약제학적 제품
|
|
EP2451835A1
(en)
|
2009-07-10 |
2012-05-16 |
ThromboGenics N.V. |
Variants of plasminogen and plasmin
|
|
ES2534911T3
(es)
*
|
2009-08-28 |
2015-04-30 |
Thrombogenics N.V. |
Uso de plasmina para el tratamiento de fallo de filtración después de trabeculectomía
|
|
EP2482822B1
(en)
|
2009-10-01 |
2018-08-01 |
Adare Pharmaceuticals, Inc. |
Orally administered corticosteroid compositions
|
|
EP2525777B1
(en)
*
|
2010-01-20 |
2019-05-29 |
UroGen Pharma Ltd. |
Material and method for treating internal cavities
|
|
US10471150B2
(en)
*
|
2010-01-20 |
2019-11-12 |
Urogen Pharma Ltd. |
Material and method for treating internal cavities
|
|
RU2604807C2
(ru)
|
2011-01-05 |
2016-12-10 |
ТромбоДженикс НВ |
Варианты плазминогена и плазмина
|
|
CA2829241A1
(en)
|
2011-04-01 |
2012-10-04 |
University Of Florida Research Foundation, Inc. |
Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
|
|
EP2734187B1
(en)
*
|
2011-07-20 |
2018-09-05 |
UroGen Pharma Ltd. |
Materials and method for treating internal body cavities
|
|
JP6000353B2
(ja)
|
2011-08-12 |
2016-09-28 |
スロンボジェニックス・ナムローゼ・フェンノートシャップＴｈｒｏｍｂｏＧｅｎｉｃｓ ＮＶ |
プラスミノーゲンおよびプラスミンの変異体
|
|
DK2836200T3
(da)
*
|
2012-04-08 |
2020-09-21 |
Urogen Pharma Ltd |
Termoreversible hydrogelpræparater til anvendelse i behandlingen af lidelser i urothelium
|
|
FR2994844B1
(fr)
*
|
2012-08-31 |
2015-01-02 |
Assist Publ Hopitaux De Paris |
Formulation gelifiante a base de ketamine
|
|
WO2014039987A2
(en)
|
2012-09-09 |
2014-03-13 |
Prothera Biologics, Inc. |
Treatment of disease using inter-alpha inhibitor proteins
|
|
US11931227B2
(en)
|
2013-03-15 |
2024-03-19 |
Cook Medical Technologies Llc |
Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
|
|
WO2015034678A2
(en)
|
2013-09-06 |
2015-03-12 |
Aptalis Pharmatech, Inc. |
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
|
|
US9801854B1
(en)
*
|
2014-01-17 |
2017-10-31 |
Urogen Pharma Ltd. |
Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer
|
|
AR100864A1
(es)
*
|
2014-06-09 |
2016-11-09 |
Klox Tech Inc |
Composiciones biofotónicas termoendurecibles y sus usos
|
|
JP6668327B2
(ja)
|
2014-08-11 |
2020-03-18 |
ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジＢｏａｒｄ Ｏｆ Ｓｕｐｅｒｖｉｓｏｒｓ Ｏｆ Ｌｏｕｉｓｉａｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ａｎｄ Ａｇｒｉｃｕｌｔｕｒａｌ Ａｎｄ Ｍｅｃｈａｎｉｃａｌ Ｃｏｌｌｅｇｅ |
生理活性で、ナノカプセル化された抗酸化物質の送達
|
|
DE102016001176A1
(de)
*
|
2016-02-03 |
2017-08-03 |
Audi Ag |
Kraftfahrzeug
|
|
TWI777515B
(zh)
|
2016-08-18 |
2022-09-11 |
美商愛戴爾製藥股份有限公司 |
治療嗜伊紅性食道炎之方法
|
|
US20190269765A1
(en)
|
2016-09-13 |
2019-09-05 |
Prothera Biologics, Inc. |
Methods for treating pulmonary disease using inter-alpha inhibitor proteins
|
|
AU2018258466B2
(en)
|
2017-04-25 |
2025-05-22 |
Prothera Biologics, Inc. |
Methods for quantifying inter-alpha inhibitor proteins
|
|
EP3790856A4
(en)
*
|
2018-05-08 |
2022-03-02 |
University of Connecticut |
LONG-ACTING LOCAL ANESTHETIC FORMULATION
|
|
US20210236657A1
(en)
*
|
2018-08-06 |
2021-08-05 |
Oregon Health & Science University |
Nerve-specific fluorophore formulations for direct and systemic administration
|
|
WO2020059543A1
(ja)
*
|
2018-09-20 |
2020-03-26 |
富士フイルム株式会社 |
生体材料
|
|
CN112043827B
(zh)
*
|
2019-05-20 |
2023-10-20 |
复旦大学 |
温敏性药物组合物、透皮制剂及其制备方法和应用
|
|
EP4259093B1
(en)
|
2020-12-11 |
2025-08-13 |
UroGen Pharma Ltd. |
Material and method for treating cancer
|